AGP Picks
View all

The Boston Examiner: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Boston Examiner.

Press releases published on November 6, 2026

RemodelWerks Launches Dedicated Turn-Key ADU Program and Specialist Team in Massachusetts
CoCountant Named a Fall 2026 Clutch Global Award Winner for Accounting
Amwell makes grant to new employees under inducement plan
Spyre Therapeutics Announces Grants of Inducement Awards
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
LeMaitre to Participate in Upcoming Investor Conferences
Candel Therapeutics Presents SITC 2026 Data Highlighting Systemic Immune Activation and Survival Outcomes Across Clinical-Stage Portfolio
Compass Therapeutics Presents Novel Mechanism of Action Data for CTX-10726 (PD-1 x VEGF-A Bispecific Antibody) at the SITC 2026 Annual Meeting
Atebimetinib Combinations with Anti-PD1 Cured 50% of Mice in a RAS-Mutant Colorectal Cancer Model and Nearly Doubled Survival in a RAS-Mutant Lung Cancer Model; New Data Presented at SITC 2026
Minerva Neurosciences Provides Third Quarter 2026 Financial Results and Business Updates
Acrivon Expands into Immunology and Inflammation with Acquisition of Phase 2-Ready Differentiated, Oral JAK1 Inhibitor ACR-525, and PKCθ Inhibitor Preclinical Program from Aqilion AB
Anika Reports Third Quarter 2026 Financial Results
Revfer Now Helps Startups Keep Their Social Media Posting, No Prompts Needed
Korro to Present at the 2026 Jefferies Global Healthcare Conference in London
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Fractyl Health to Report Third Quarter 2026 Financial Results and Provide Business Updates on November 12, 2026
EyePoint Announces Participation at Upcoming Investor Conferences and Scientific Meetings
Eccogene to Present Preclinical Data of Small Molecule Amylin and Calcitonin Receptor Agonist ECC1542 at ObesityWeek® 2026
Global Hydrogen Gas Turbines Market to Reach $7.5 Billion by 2031, Driven by Industrial Decarbonization Mandates and Data Center Power Demand
Molecular Partners Presents New Preclinical Data for Next-Generation T Cell Engager MP0632 at SITC 2026

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

The Boston Examiner

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.